Хлебные крошки
- Главная
-
Аналитика
-
Акции
Акции внутренные
XOMA Corporation XOMA
$19.11
+$0.58 (3.02%)
На 18:00, 12 мая 2023
Ранг: 3
Ключевые показатели
-
Marketcap
211587252.00000000
-
week52high
32.09
-
week52low
15.68
-
Revenue
6027000
-
P/E TTM
-12
-
Beta
0.83944600
-
EPS
-1.98000000
-
Last Dividend
0.00000000
-
Next Earnings Date
04 мая 2023 г. в 12:30
Описание компании
XOMA Corporation operates as a biotechnology royalty aggregator in Europe, the United States, and the Asia Pacific. The company engages in helping biotech companies for enhancing human health. It acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceutical or biotechnology companies. The company focuses on early to mid-stage clinical assets primarily in Phase 1 and 2 with commercial sales potential that are licensed to partners. It has a portfolio with approximately 70 assets. XOMA Corporation was incorporated in 1981 and is headquartered in Emeryville, California.
Рекомендации
аналитиков
Рекомендации аналитиков
| Grading company | New grade | Previous grade | Recommendation date |
|---|---|---|---|
| HC Wainwright & Co. | Buy | Buy | 08 окт 2021 г. |
| Aegis Capital | Buy | Buy | 09 сент 2021 г. |
| Wedbush | Neutral | Outperform | 07 сент 2021 г. |
| Aegis Capital | Buy | 29 июн 2021 г. | |
| Wedbush | Outperform | Neutral | 05 сент 2017 г. |
Свежие комментарии
Свежие комментарии
Оставьте свой голос
Оставьте свой голос
Анонимное голосование
Будет ли рост российского рынка к концу года?
-
Да
87% -
Нет
12%
Проголосовал 8 человек
Новостная лента
компании
Insider Summary
Insider Summary
| Reporting Name | Acquistion/Disposition | Owned | Transacted | Transaction Date |
|---|---|---|---|---|
| BVF PARTNERS L P/IL | A | 1618637 | 1573 | 06 янв 2023 г. |
| BVF PARTNERS L P/IL | A | 1789844 | 1676 | 06 янв 2023 г. |
| BVF PARTNERS L P/IL | A | 1617064 | 15670 | 05 янв 2023 г. |
| BVF PARTNERS L P/IL | A | 1788168 | 3330 | 05 янв 2023 г. |
| Sitko Bradley | A | 250000 | 250000 | 03 янв 2023 г. |
| Sitko Bradley | A | 300000 | 300000 | 03 янв 2023 г. |
| Hughes Owen | A | 75000 | 75000 | 03 янв 2023 г. |
| Hughes Owen | A | 100000 | 100000 | 03 янв 2023 г. |
| BURNS THOMAS M. | A | 11000 | 11000 | 08 ноя 2022 г. |
| BVF PARTNERS L P/IL | A | 1601394 | 678 | 27 сент 2022 г. |
Новостная лента
XOMA to Present at H.C. Wainwright BioConnect Investor Conference
GlobeNewsWire
26 апр 2023 г. в 07:30
EMERYVILLE, Calif., April 26, 2023 (GLOBE NEWSWIRE) -- XOMA Corporation (NASDAQ: XOMA), the Biotech Royalty Aggregator, announced today Owen Hughes, Executive Chairman, and Brad Sitko, Chief Investment Officer, will be featured in a fireside chat at the H.C. Wainwright BioConnect Investor Conference on Tuesday, May 2, 2023, at 10:30 AM ET.
XOMA to Present at 43rd Annual Cowen Health Care Conference
GlobeNewsWire
28 февр 2023 г. в 07:30
EMERYVILLE, Calif., Feb. 28, 2023 (GLOBE NEWSWIRE) -- XOMA Corporation (NASDAQ: XOMA), the Biotech Royalty Aggregator, announced today that Owen Hughes, Executive Chairman, and Brad Sitko, Chief Investment Officer, will be featured in a fireside chat at the 43rd Annual Cowen Health Care Conference on Tuesday, March 7, 2023, at 2:10 PM ET.
XOMA to Present at H.C. Wainwright 24th Annual Global Investment Conference
GlobeNewsWire
07 сент 2022 г. в 07:30
EMERYVILLE, Calif., Sept. 07, 2022 (GLOBE NEWSWIRE) -- XOMA Corporation (Nasdaq: XOMA), a biotechnology royalty aggregator playing a distinctive role in helping companies achieve their goal of improving human health, announced today its Chairman and Chief Executive Officer, Jim Neal, will present at the H.C. Wainwright 24th Annual Global Investment Conference on Monday, September 12, 2022, at 10:00 AM ET.
Xoma (XOMA) Reports Q2 Loss, Misses Revenue Estimates
Zacks Investment Research
04 авг 2022 г. в 12:02
Xoma (XOMA) delivered earnings and revenue surprises of -381.82% and 88.42%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?